Effects of screening mammography on the comparative survival rates of African American, white, and Hispanic beneficiaries of a comprehensive health care system

The Breast Journal
Barbara E WojcikCatherine R Stein

Abstract

This study reviewed mammographic screening related to breast carcinoma diagnosis and treatment between 1987 and 1997 at Brooke Army Medical Center, San Antonio, TX. Epidemiologic data from the Department of Defense Automated Central Tumor Registry were merged with data from patients' medical records and responses of the patients or their families to a mailed survey. The cases of 907 women grouped by race-white, African American, and Hispanic-were analyzed. Breast carcinoma diagnosed by mammographic screening showed a reversed ratio of early to late stage of cancer occurring for all three groups. That ratio was 1.45 for African Americans, 2.67 for Hispanics, and 3.08 for whites. For those women diagnosed with screening mammography, no statistically significant difference in 5-year survival was found between the races: 86% for whites, 83% for Hispanics, and 80% for African Americans. Mammographic screening as a diagnostic tool appears to equalize survival among whites, Hispanics, and African Americans, in spite of differences in age, stage of diagnosis, and military rank used as a proxy for socioeconomic status. When not controlling for mammographic diagnosis, Kaplan-Meier analysis revealed significant differences in survival pat...Continue Reading

References

Oct 1, 1992·American Journal of Public Health·B L Wells, J W Horm
Nov 7, 1990·Journal of the National Cancer Institute·R J CoatesR L Brown
Oct 15, 1988·BMJ : British Medical Journal·I AnderssonB Sigfússon
Jan 1, 1986·Journal of Chronic Diseases·R P BainJ P Whitaker
Jan 1, 1982·Journal of Chronic Diseases·H H DayalC Chiu
Apr 1, 1995·Annals of Internal Medicine·E A Sickles, D B Kopans
May 4, 1994·Journal of the National Cancer Institute·R M ElledgeC K Osborne
Jan 1, 1993·American Journal of Public Health·E E CalleL M Martin
May 15, 1996·Annals of Internal Medicine·J Moormeier
Aug 1, 1996·Annals of Internal Medicine·R B BurnsM A Moskowitz
Jan 1, 1997·Annals of Surgical Oncology·G H LymanP Baekey
Jan 1, 1997·Breast Cancer Research and Treatment·A J Zaloznik
May 1, 1997·American Journal of Public Health·F Chevarley, E White
Jun 17, 1998·JAMA : the Journal of the American Medical Association·D R LanninM S Edwards
Nov 21, 1998·Cancer Detection and Prevention·P GhadirianP Boyle
Nov 21, 1998·Cancer Detection and Prevention·S J RolnickL M Loes
Oct 16, 1999·American Journal of Clinical Oncology·H AzizM Rotman
Nov 27, 1999·Archives of Family Medicine·K C ChuO W Brawley
Feb 7, 2001·American Journal of Epidemiology·P G MoormanB Newman
Feb 24, 2001·American Journal of Public Health·A M Marbella, P M Layde

❮ Previous
Next ❯

Citations

Dec 3, 2005·Breast Cancer Research and Treatment·Michael S SimonKendra Schwartz
Dec 2, 2009·Breast Cancer Research and Treatment·Elena M KouriNancy L Keating
Dec 3, 2011·Journal of Spinal Disorders & Techniques·Andrew J SchoenfeldJohn J Walker
Jan 13, 2012·PloS One·Xuejuan JiangManuela Gago-Dominguez
Jul 14, 2012·PloS One·Carmen M RedondoJ Esteban Castelao
Jun 3, 2008·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Jaeyoung Kim, Soong Nang Jang
Oct 7, 2008·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·M W RetskyI D Gukas
May 15, 2015·Journal of Community Health Nursing·Michèle M Schlehofer, Tina P Brown-Reid
Oct 16, 2015·Ciência & saúde coletiva·Juliana Dantas RodriguesAdriano Nascimento Paixão

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved